15 results  1 of 1 

1 Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial
Keun-Sik Hong, Oh Young Bang, Jong-Ho Park, Jin-Man Jung, Sang-Hun Lee, Tae-Jin Song, Hyo Suk Nam, Hee-Kwon Park, Keun-Hwa Jung, Sung Hyuk Heo, Jaseong Koo, Kyung-Ho Yu, Kwang-Yeol Park, Chi Kyung Kim, Hong-Kyun Park, Jiyoon Lee, Juneyoung Lee, Woo-Keun Seo
J Stroke.2023;25(2):242-250.   Published online 2023 April 11     DOI: http://dx.doi.org/10.5853/jos.2022.02957
      
2 Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors
Jah Yeon Choi, Jin Oh Na
J Lipid Atheroscler.2019;8(2):183-191.   Published online 2019 September 17     DOI: http://dx.doi.org/10.12997/jla.2019.8.2.183
      
3 Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus
You-Cheol Hwang, Ji Eun Jun, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung
Diabetes Metab J.2019;43(5):582-589.   Published online 2019 January 16     DOI: http://dx.doi.org/10.4093/dmj.2018.0124
      
4 What Do We Get from Recent Statin and CETP Inhibitors Trials?
Byung Jin Kim
J Lipid Atheroscler.2018;7(1):12-20.   Published online 2018 May 30     DOI: http://dx.doi.org/10.12997/jla.2018.7.1.12
      
5 Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis
Namki Hong, Yong-ho Lee, Kenichi Tsujita, Jorge A. Gonzalez, Christopher M. Kramer, Tomas Kovarnik, George N. Kouvelos, Hiromichi Suzuki, Kyungdo Han, Chan Joo Lee, Sung Ha Park, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
Endocrinol Metab.2018;33(2):219-227.   Published online 2018 May 4     DOI: http://dx.doi.org/10.3803/EnM.2018.33.2.219
   
6 Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects
Inyoung Hwang, Sang-In Park, SeungHwan Lee, BackHwan Lee, Kyung-Sang Yu, Ji-Young Jeon, Min-Gul Kim
Transl Clin Pharmacol.2018;26(1):16-24.   Published online 2018 March 16     DOI: http://dx.doi.org/10.12793/tcp.2018.26.1.16
      
7 Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers
Jungsin Park, Choon Ok Kim, Byung Hak Jin, Seoungwon Yang, Min Soo Park, Taegon Hong
Transl Clin Pharmacol.2017;25(4):202-208.   Published online 2017 December 20     DOI: http://dx.doi.org/10.12793/tcp.2017.25.4.202
      
8 Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
Joong-Woon Choi, Dong-Woo Suh, Bark-Lynn Lew, Woo-Young Sim
Ann Dermatol.2017;29(6):755-760.   Published online 2017 October 30     DOI: http://dx.doi.org/10.5021/ad.2017.29.6.755
      
9 The Glucotoxicity Protecting Effect of Ezetimibe in Pancreatic Beta Cells via Inhibition of CD36
Ji Sung Yoon, Jun Sung Moon, Yong-Woon Kim, Kyu Chang Won, Hyoung Woo Lee
J Korean Med Sci.2016;31(4):547-552.   Published online 2016 March 9     DOI: http://dx.doi.org/10.3346/jkms.2016.31.4.547
      
10 Combination pharmacotherapy in lipid management
Sang-Hak Lee
J Korean Med Assoc.2015;58(8):745-749.   Published online 2015 August 29     DOI: http://dx.doi.org/10.5124/jkma.2015.58.8.745
      
11 Effect of Pretreatment of Ezetimibe/Simvastatin on Arterial Healing and Endothelialization after Drug-Eluting Stent Implantation in a Porcine Coronary Restenosis Model
Doo Sun Sim, Myung Ho Jeong, Dae Sung Park, Jung Ha Kim, Kyung Seob Lim, Hyun Kuk Kim, Sung Soo Kim, Jae Yeong Cho, Hae Chang Jeong, Keun Ho Park, Young Joon Hong, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park
Korean Circ J.2015;45(2):110-116.   Published online 2015 March 24     DOI: http://dx.doi.org/10.4070/kcj.2015.45.2.110
      
12 Update on the Pharmacologic Agents for Dyslipidemia
Sang-Hak Lee
J Korean Diabetes.2015;16(4):269-275.   Published online 2015 January 10     DOI: http://dx.doi.org/10.4093/jkd.2015.16.4.269
   
13 Influence of Previous Statin Therapy on Cholesterol-Lowering Effect of Ezetimibe
Young Hwan Choi, Young Kim, Cheol Won Hyeon, Seonghyup Hyun, Jee Eun Kwon, Hoyoun Won, Seung Yong Shin, Wang-Soo Lee, Kwang Je Lee, Sang-Wook Kim, Tae Ho Kim, Chee Jeong Kim
Korean Circ J.2014;44(4):227-232.   Published online 2014 July 25     DOI: http://dx.doi.org/10.4070/kcj.2014.44.4.227
      
14 Familial Hypercholesterolemia and the Atherosclerotic Disease
Yoo Ri Kim, Ki Hoon Han
Korean Circ J.2013;43(6):363-367.   Published online 2013 June 30     DOI: http://dx.doi.org/10.4070/kcj.2013.43.6.363
      
15 Comparison of Ezetimibe/Simvastatin 10/20 mg Versus Atorvastatin 20 mg in Achieving a Target Low Density Lipoprotein-Cholesterol Goal for Patients With Very High Risk
Yun-Kyeong Cho, Seung-Ho Hur, Chun-Duk Han, Hyoung-Seob Park, Hyuck-Jun Yoon, Hyungseop Kim, Chang-Wook Nam, Yoon-Nyun Kim, Kwon-Bae Kim, Nam-Hee Park, Hee-Jun Park
Korean Circ J.2011;41(3):149-153.   Published online 2011 March 31     DOI: http://dx.doi.org/10.4070/kcj.2011.41.3.149
      

 1 of 1